换一批
换一批A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.
第一作者：
J,Labenz
第一单位：
Department of Medicine, Jung-Stilling Hospital, Siegen, Germany. J.Labenz@t-online.de
作者：
主题词
2-吡啶甲基亚硫酰苯咪唑类(2-Pyridinylmethylsulfinylbenzimidazoles);药物副反应报告系统(Adverse Drug Reaction Reporting Systems);抗溃疡病药(Anti-Ulcer Agents);抗凝药(Anticoagulants);苯咪唑类(Benzimidazoles);药物相互作用(Drug Interactions);胃肠疾病(Gastrointestinal Diseases);人类(Humans);奥美拉唑(Omeprazole);质子泵抑制剂(Proton Pump Inhibitors);亚砜类(Sulfoxides);美国(United States);美国食品和药物管理局(United States Food and Drug Administration)
DOI
10.1046/j.1365-2036.2003.01550.x
PMID
12694083
发布时间
2019-09-01
- 浏览128
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
